Wu R - Search Results

1

Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT).

Zhou S, Wang C, Shen L, Wang Y, Zhang H, Wu R, Wang Y, Chen Y, Xuan Y, Xia F, Zhang Z, Wan J. Zhou S, et al. Among authors: wu r. Front Oncol. 2023 Oct 5;13:1274487. doi: 10.3389/fonc.2023.1274487. eCollection 2023. Front Oncol. 2023. PMID: 37869085 Free PMC article.

2

Choice of Treatment for Patients With Non-small-cell Lung Cancer >5 cm Between Surgery Alone and Surgery Plus Adjuvant Radiotherapy.

Wang B, Zhou Y, Jia M, Yan Z, Chen J, Lu X, Wu R, Wen J. Wang B, et al. Among authors: wu r. Front Surg. 2021 Mar 9;8:649802. doi: 10.3389/fsurg.2021.649802. eCollection 2021. Front Surg. 2021. PMID: 33768112 Free PMC article.

3

Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).

Wang Y, Shen L, Wan J, Zhang H, Wu R, Wang J, Wang Y, Xu Y, Cai S, Zhang Z, Xia F. Wang Y, et al. Among authors: wu r. BMC Cancer. 2022 Mar 15;22(1):274. doi: 10.1186/s12885-022-09348-z. BMC Cancer. 2022. PMID: 35291966 Free PMC article. Clinical Trial.

4

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation.

Wang Y, Shen L, Wan J, Zhang H, Wu R, Wang J, Wang Y, Xu Y, Cai S, Zhang Z, Xia F. Wang Y, et al. Among authors: wu r. Front Immunol. 2022 Dec 8;13:1067036. doi: 10.3389/fimmu.2022.1067036. eCollection 2022. Front Immunol. 2022. PMID: 36569918 Free PMC article. Review.

5

Immunotherapy and tumor mutational burden in cancer patients with liver metastases: A meta and real word cohort analysis.

Wu RY, Wang BC, Wang K, Xia F, Zhang ZY, Wan JF, Zhang Z. Wu RY, et al. Front Oncol. 2023 Jan 19;12:994276. doi: 10.3389/fonc.2022.994276. eCollection 2022. Front Oncol. 2023. PMID: 36741738 Free PMC article.

6

Long-term outcomes in a retrospective cohort of patients with rectal cancer with complete response after total neoadjuvant therapy: a propensity-score weighted analysis.

Wang J, Zhang L, Wang M, Zhang J, Wang Y, Wan J, Li G, Zhang H, Wang Y, Wu R, Zhang Z, Li X, Xu Y, Zhu J, Shen L, Xia F, Zhang Z. Wang J, et al. Among authors: wu r. Ther Adv Med Oncol. 2023 Sep 8;15:17588359231197955. doi: 10.1177/17588359231197955. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37701810 Free PMC article.

7

Short-course radiotherapy combined with chemotherapy and PD-1 inhibitor in low-lying early rectal cancer: study protocol for a single-arm, multicentre, prospective, phase II trial (TORCH-E).

Chen Y, Wang Y, Zhang H, Wan J, Shen L, Wang Y, Zhou M, Wu R, Yang W, Zhou S, Cai S, Li X, Zhang Z, Xia F. Chen Y, et al. Among authors: wu r. BMJ Open. 2023 Oct 6;13(10):e076048. doi: 10.1136/bmjopen-2023-076048. BMJ Open. 2023. PMID: 37802608 Free PMC article.

8

RIFLE: a Phase II trial of stereotactic ablative radiotherapy combined with fruquintinib and tislelizumab in metastatic colorectal cancer.

Wang K, Chen Y, Zhang Z, Wu R, Zhou M, Yang W, Wan J, Shen L, Zhang H, Wang Y, Han X, Wang J, Zhang Z, Xia F. Wang K, et al. Among authors: wu r. Gastroenterol Rep (Oxf). 2023 Oct 11;11:goad063. doi: 10.1093/gastro/goad063. eCollection 2023. Gastroenterol Rep (Oxf). 2023. PMID: 37842200 Free PMC article.

9

TORCH-R trial protocol: hypofractionated radiotherapy combined with chemotherapy and toripalimab for locally recurrent rectal cancer: a prospective, single-arm, two-cohort, phase II trial.

Wan J, Wu R, Fu M, Shen L, Zhang H, Wang Y, Wang Y, Zhou S, Chen Y, Xia F, Zhang Z. Wan J, et al. Among authors: wu r. Front Oncol. 2023 Nov 20;13:1304767. doi: 10.3389/fonc.2023.1304767. eCollection 2023. Front Oncol. 2023. PMID: 38053659 Free PMC article.

10

Study protocol of short-course radiotherapy combined with CAPOX and PD-1 inhibitor for locally advanced colon cancer: a randomised, prospective, multicentre, phase II trial (TORCH-C).

Zhang H, Li Y, Xia F, Sun Y, Shen L, Wan J, Chen Y, Wang Y, Zhou M, Wu R, Zhou S, Wang Y, Liu F, Cai S, Zhang Z. Zhang H, et al. Among authors: wu r. BMJ Open. 2024 Feb 2;14(2):e079442. doi: 10.1136/bmjopen-2023-079442. BMJ Open. 2024. PMID: 38309748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11,135 results

Search Page